Coronary artery disease is the major cause of death in Scotland. The Registrar General attributed 17 656 deaths to this cause in 1971. This represents 28.6% of all deaths, one-third of all male deaths, and one-quarter of all female deaths (Registrar General 1972) .
In the light of current knowledge of the importance of risk factors in the development of overt coronary artery disease (Kannel et al. 1964 , Carlson & Bottiger 1972 and the lack of prevalence data for the Scottish population, a survey was undertaken of apparently healthy working males in the West of Scotland (Lorimer et al. 1974) . The sample consisted of 4477 men, half in manual and half in non-manual occupations, forming an important economic section of the community. Table 1 illustrates the origins of the selected sub-groups and the response rates.
Assessment included a questionnaire, blood pressure, recording electrocardiograph, chest X-ray and autoanalyser assay of a fasting plasma sample for total cholesterol (Annan & Isherwood 1969) and total triglycerides (Kessler & Lederer 1966) together with electrophoresis by the method of Lees & Hatch (1963) . Where chylomicrons were present, the importance of fasting was reemphasized and the sampling was repeated.
The age-related upper normal limits suggested by Fredrickson et al. (1967) were used to delineate abnormality in this population. Table 2 shows the prevalence of abnormalities. Smoking, obesity and hyperlipidmmia are particularly prevalent. Table 3 illustrates the prevalence of hyperlipoproteinmmia (HLP) in this population. The type IV abnormality is particularly common, especially in the obese group, although when the obese group is excluded, there still remains a prevalence of 7 %, twice that of the type II abnormality.
Less than a dozen males had a type IIb abnormality and types I, III and V (Fredrickson classification) were not found.
It should perhaps be emphasized that the analytical techniques used may underestimate the prevalence of type II abnormality, as an elevated LDL cholesterol may escape detection, where total plasma cholesterol remains within the normal range.
Comparison with other prevalence studies is rendered difficult owing to differences of methodo-Dr J L H C Third logy and patient selection. The use of cut-off values for total cholesterol of 6.21 and 7.12 mmol/l for the entire group (240 and 275 mg/ 100 ml) gives prevalence rates for hypercholesterolmmia of 38.3% and 13.3% respectively, which compares with the rate of 8% found at a cut-off point of 6.73 mmol/l (260 mg/100 ml) in some 2500 Edinburgh males surveyed by Oliver (1974) . Our figures may be compared with the rate of 21.4% found at a cut-off level of 7.21 mmol/l (275 mg/100 ml) described in a survey of HLP in post-infarction patients or those with angina. A study of 133 consecutive patients undergoing coronary angiography for diagnosis of atypical chest pain or for consideration for coronary vein graft bypass surgery demonstrated the anticipated increase in hyperlipoprotein3mia in patients with coronary artery disease (Murray et al. 1975 ). Perhaps of greater interest is the demonstration of a relation between severity of disease, estimated as the number of vessels involved on the angiogram (>50% occlusion) and the presence of a hyperlipoproteinemia, detected by full beta-quantification on fasting plasma (Table 3 ). Plasma cholesterol concentrations increased with increasingly severe coronary artery disease and were higher in younger patients with coronary artery disease than in older patients. Plasma triglyceride levels similarly increased with the severity of coronary artery disease, but were only significantly higher than the group with normal vessels when two or three vessels were involved. Triglyceride levels were significantly higher in younger than in older patients. The prevalence study of apparently healthy working males found a decline in plasma cholesterol and triglyceride levels with advancing age, and this may be pertinent to these high values noted in younger patients with coronary artery disease.
A similar relation between cholesterol and coronary artery disease was reported by Banks et al. (1971) and by Barboriak et al. (1974) . Cramer et al. (1966) found no relation between cholesterol and vessel damage, but did find z raised triglyceride level more frequently ii severe coronary artery disease. Salel et al. (1974) found obesity and type IV HLP to be significantly increased in young patients with coronary artery disease. Heinle et al. (1969) found no relation between LDL cholesterol, triglyceride and vessel disease.
Angiographic studies of patients referred to our Chest Pain Clinic with angina have shown about half to possess triple vessel disease. Patients with angina of effort have a high probability of hyperlipoproteinemia.
A survey was performed by Ballantyne & Lawrie (1973) of 353 patients with proven atherosclerotic peripheral vascular disease who were admitted to a vascular surgery unit for assessment and possible surgery. Lipoprotein parameters were measured by ultracentrifugation and heparin-manganese precipitation on fasting plasma. LDL cholesterol assay gave a significantly increased incidence of 29.5 % type IIa abnormality in women compared to 7.5% in men. Type IIb and IV abnormalities did not show significant sex differences. Peripheral vascular disease patients usually have generalized atherosclerosis and (Veitch 1970 ). The prevalence rates in this survey are similar to those reported by Wood et al. (1972) for community health volunteers in California, where the age-related upper limits gave rates of 2.8 % of type II and 13 % of type IV. Differences in the prevalence of type IV in other studies may be due to inclusion of a greater number of obese individuals. Studies in California (Wood et al. 1972) and Stockholm (Carlson & B6ttiger 1972) have demonstrated higher triglyceride levels than this survey. The mean triglyceride level is increased by 0.52-0.78 mmol/l (20-30 mg/100 ml) in obese subjects. Obesity has no significant effect on the prevalence of the type II abnormality.
A decrease in the prevalence of hyperlipoproteinwmias with advancing age was found in this study, suggesting that the age-related rise in cholesterol and triglyceride levels described by Fredrickson et al. (1967) in an American population does not apply to this Scottish group.
A further survey of 420 working women, not taking oral contraceptives, employed by the Singer Company, utilized measurement of fasting total plasma cholesterol and triglycerides and cholesterol content of the major lipoprotein fractions. A prevalence of 1.9% for type II HLP (based on total cholesterol) and 6% type IV (based on total triglycerides) was found. Oliver (1974) found type Ila to be the commonest lipoprotein abnormality in 145 women with ischemic heart disease, and it may be the case that LDL cholesterol assay selects a high risk group.
Turning from the apparently healthy population to patients, we have, in keeping with severa other studies, noted an increased prevalence of suffer a high mortality from coronary artery disease as well as the morbidity and mortality attendant upon the peripheral vascular disease.
The University Department of Medical Cardiology runs the major lipoprotein clinic in the West of Scotland. Referrals come principally from the high risk groups, namely post-infarction patients or those with angina. Virtually all the peripheral vascular disease patients are referred to the lipoprotein clinic for screening and treatment of HLP if present. Patients are also referred with the superficial stigmata of hyperlipoproteinEemia and those discovered by chance sampling to have HLP.
The policy is aggressive therapy for these high risk individuals, particularly type II patients. Also screened are the relatives of index patients, those found to have HLP being regarded as high risk candidates for coronary artery disease. The rigorous treatment of type IV patients is less clear, in view of its wide prevalence in the community. It seems particularly related to obesity and alcohol consumption. Thus therapy and advice are tailored to the individual patient.
The current approach to treatment is as follows:
(1) Secondary HLP is excluded.
(2) The abnormality is defined with full beta quantificationl on at least three fasting samples.
(3) Dietary alteration is the mainstay of the therapeutic approach. This includes instruction from a professional dietician at the clinic, with advice on low cholesterol intake; weight reduction; low carbohydrate consumption; combination diets (type Ilb); alcohol restriction (type IV). In most cases there is lifelong annual review.
(4) Drugs are used only where dietary response is inadequate or where, after perhaps three to six months, the patient has proved unable or unwilling to change his diet. In the main, cholestyramine is used for type II and clofibrate for type IV patients. It has been found necessary to review these patients as the patterns of the lipoprotein abnormality alter, substituting perhaps one risk factor for another. In particular, LDL levels may rise in patients on clofibrate and, more commonly, patients on cholestyramine and dietary treatment for hypercholesterolhmia may develop a type IV abnormality. These secondary phenomena may themselves require treatment.
The exigencies of the current economic situation preclude population surveys on the scale of that just described. A survey of 1500 neonatal cord blood lipoprotein levels with repeat sampling of child and both parents one year later is being completed, to determine whether the familial type II abnormality is detectable at a stage when disease is not established and perhaps is most amenable to therapy. The type IV abnormality is not manifest until much later in life. Current policies appear to be unsatisfactory, in that they deal with an established disease process where benefit may be minimal, although animal studies and postmortem studies of humans dying of cachexia do suggest that the fibrous element of atheroma, as well as the lipid moiety, may be a reversible lesion (Gresham 1976) .
The recent support of the COMA report (DHSS 1974) for dietary saturated fat is reducing for it is surely at a national level that risk factors such as smoking or hyperlipidtmia, in the majority affected, are most amenable to therapy. But it is also important to remember that a hyperlipidwmia is not an inevitable precursor of coronary artery disease and, without attention to other risk factors, may be a poor prognostic indicator.
In this regard, we have initiated a coronary angiographic study of familial hyperlipidemic relatives of badly affected index patients to determine the stage of their disease. Early screening, detection and therapy seems an ideal approach, but it may lead to unnecessary therapy for large numbers of individuals, unless more specific screening methods become available.
